ArticleACG case reports journal2026

Infliximab-Responsive Severe Ulcerative Colitis With Pyoderma Gangrenosum After IL-6 and IGF-1 Blockade.

Shinobu Onishi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.